Evidence map›Paper›PMID 15682295›Full record

ArticlePsychopharmacology2005

Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: a potential role for sodium channels?

N R Mirza, J L Bright, K J Stanhope, A Wyatt, N R Harrington

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
10.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Decreased BOLD Signal Variability in Middle-Aged and Older Adults on the Autism Spectrum.Autism research : official journal of the International Society for Autism Research · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Lamotrigine, an antiepileptic drug, inhibits 5-HTThe Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Pharmacodynamics of memantine: an update.Current neuropharmacology · 2008
    Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

N R MirzaDepartment of Neuropharmacology, Vernalis PLC, Oakdene Court, 613 Reading Road, Winnersh, Wokingham RG41 5UA, UK. max@neurosearch.dk
J L Bright
K J Stanhope
A Wyatt
N R Harrington
NeuroSearch (Denmark) · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleMany anticonvulsants are used in disorders other than epilepsy. For example, lamotrigine is reported to be effective in post-traumatic stress disorder and mania.

objectiveWe assessed the effects of the anticonvulsants lamotrigine, valproate and carbamazepine in an animal model of anxiety. We assessed a wide range of pharmacological tools to delineate the mechanism of lamotrigine's anxiolytic effect.

methodsWe assessed these compounds in the rat conditioned emotional response (CER) test of anxiety.

resultsLamotrigine (30-80 mg/kg) dose-dependently and reproducibly engendered an anxiolytic response in this test, with similar efficacy to benzodiazepines. Carbamazepine (20-40 mg/kg) and riluzole (10 mg/kg), which block Na+ channels by a similar mechanism as lamotrigine, were also anxiolytic. By contrast, valproate (100-600 mg/kg) was inactive and appears to differ in its interaction with Na+ channels. The SSRI paroxetine, the GABA(A) receptor positive modulator propofol, the NMDA antagonists memantine and (+)MK-801, and the Ca2+ channel antagonist nifedipine were all inactive in the CER test, suggesting these mechanisms may not mediate the anxiolytic effect of lamotrigine. More directly, we showed that the anxiolytic effect of lamotrigine could be blocked by co-administering rats with the Na+ channel activator veratrine (0.1 mg/kg). By contrast, neither the Ca2+ channel agonist BAYK8644 (0.5 mg/kg) nor the 5-HT1A or 5-HT(1/2) antagonists WAY100635 (0.3 mg/kg) and metergoline (3 mg/kg), respectively, were able to block the effect.

conclusionLamotrigine's anxiolytic effect in the CER test may be mediated via block of Na+ channels, and this may represent a target for the development of novel anxiolytics.

Indexed as

AnimalsAnti-Anxiety AgentsAnticonvulsantsAnxietyCalcium Channel AgonistsCalcium Channel BlockersConditioning, ClassicalDisease Models, AnimalDose-Response Relationship, DrugEmotionsLamotrigineMaleRatsReceptors, GABA-AReceptors, N-Methyl-D-AspartateSelective Serotonin Reuptake InhibitorsAnti-Anxiety AgentsAnticonvulsantsCalcium Channel AgonistsCalcium Channel BlockersLamotrigineReceptors, GABA-AReceptors, N-Methyl-D-AspartateSelective Serotonin Reuptake InhibitorsSodium Channel BlockersTriazines

Identifiers

PMID15682295
OpenAlexW1968828764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.